A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication, according ...
A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...
A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as ...
A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...
The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in US patients hospitalized with heart failure (HF) and a left ...
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...
A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...
A new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients also have atrial fibrillation – a combination of cardiac disorders ...
The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...
A new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients also have atrial fibrillation – a combination of cardiac disorders ...
19hon MSN
A new study by heart researchers at Intermountain Health in Salt Lake City finds that patients with heart disease, ...
The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback